From: Survivorship and prognostic factors for pleomorphic liposarcoma: a population-based study
Covariates | Hazard ratio | 95% CI | p value |
---|---|---|---|
Age (years) | |||
< 65 | Reference group | ||
≥ 65 | 1.2 | 0.8–1.6 | 0.327 |
Site | |||
Soft tissue of extremity | Reference group | ||
Soft tissue of axial | 0.8 | 0.5 to 1.2 | 0.253 |
Internal tissue/organ | 1.0 | 0.6 to 1.6 | 0.964 |
Cancer-directed surgery | |||
Performed | Reference group | ||
Not performed | 7.6 | 3.5 to 16.7 | < 0.001 |
Size | – | – | – |
Stage | – | – | – |
Radiotherapy | – | – | – |
Size*stage | – | – | – |
Size*radiotherapy | – | – | – |